PRESS RELEASE
HIV CURE RESEARCH WORKSHOP CLINICAL REPORT
Following the last "International Workshop on HIV Persistence, Reservoirs and
Eradication Strategies", scientists are now working into translating the recent basic
discoveries into clinical trials for...
More
PRESS RELEASE
HIV CURE RESEARCH WORKSHOP CLINICAL REPORT
Following the last "International Workshop on HIV Persistence, Reservoirs and
Eradication Strategies", scientists are now working into translating the recent basic
discoveries into clinical trials for patients.
Toulon, France, January 04, 2012 -- Although a number of promising approaches have
led to testable hypotheses for an HIV cure, for which small animal and primate models
may provide preliminary information, ultimately proof of concept and validation studies in
human subjects will be required.
These trials will need to balance the risks of significant
toxicity, morbidity and mortality of novel strategies against the possible benefit to
individual patients and knowledge gained overall.
However, it is challenging to define an
acceptable level of risk in the context of generally safe and effective life-long therapy.
Would a small risk of fatal complication be acceptable? Would a modest risk of mortality,
like 1-2% for coron
Less